Neogen
NEOGNeogen Corp is a global leader in food and animal safety, providing a comprehensive suite of diagnostic products, services, and genomics testing.
Earnings
Next report
Oct 8, 2026 (in 2 months)Valuation & ratios
Competitors
By market cap
By revenue growth
Profile
Neogen Corp is a global leader in food and animal safety, providing a comprehensive suite of diagnostic products, services, and genomics testing. The company's core value proposition lies in ensuring global food security by helping producers and processors detect contaminants, manage biosecurity, and optimize animal genetics. Their business model is heavily driven by the sale of proprietary consumables and diagnostic kits used across the entire agricultural and food production value chain.
Neogen maintains a leading position by offering a uniquely broad integrated line of both food and animal safety products, which differentiates it from competitors who typically specialize in only one niche.
FAQ
- What is Neogen's market cap?
- Neogen (NEOG) has a market capitalization of $2.6B and trades on NASDAQ.
- What is Neogen's revenue and profitability?
- Neogen generated $870.5M in trailing twelve-month revenue with a net loss of $608.8M, representing a net margin of -69.9%. Gross margin stands at 45.2%, with free cash flow of -$71.9M. These figures are based on the Q1 2026 filing.
- Who are Neogen's competitors?
- Neogen's key competitors include Zoetis, IDEXX Laboratories, Thermo Fisher Scientific, and others. These companies compete in similar markets and product categories.
- Who does Neogen partner with?
- Neogen's notable partners include 3M Company.
- What subsidiaries does Neogen have?
- Neogen's subsidiaries include Megazyme, Ltd., Genetic Veterinary Sciences, Inc., Quat Chem, Ltd., and others.
- Where is Neogen headquartered?
- Neogen is headquartered in United States of America and employs approximately 2,640 people. It has been publicly traded since 1989.
